About the Product

Description


Isofyle 30 Tablet containing Isosorbide Mononitrate is used for the prevention and management of angina pectoris. It helps in improving blood flow and reducing the workload on the heart.

Isosorbide Mononitrate works by relaxing and widening blood vessels, which improves oxygen supply to the heart muscles and helps prevent chest pain episodes.

The tablet is widely prescribed in cardiology practice for long-term management of angina and related cardiac conditions, leading to consistent demand and repeat usage.

With increasing prevalence of cardiovascular diseases and growing awareness of heart health management, this product offers strong business potential for retailers and distributors. Its long-term therapy use, steady prescription demand, and broad clinical acceptance make it a reliable product for consistent sales and growth in the cardiac segment.

Some patients may experience headache, dizziness, flushing, low blood pressure, or nausea. Rarely, fainting or severe hypotension may occur and require medical attention.

Isofyle 30 Tablet is indicated for the prevention and long-term management of angina pectoris associated with coronary artery disease. It helps reduce chest pain episodes, improve exercise tolerance, and support better cardiac function.

This medicine should be used under medical supervision. Sudden discontinuation should be avoided. Patients should rise slowly from sitting or lying positions to reduce dizziness. It should not be used along with phosphodiesterase inhibitors such as Sildenafil due to the risk of severe hypotension.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Isofyle 30 Tablet in the PCD pharma franchise market?

Isofyle 30 Tablet, containing Isosorbide Mononitrate 30mg, has strong demand in the cardiology segment, making it a stable and profitable product for medical distributors, wholesalers, and pharma franchise partners focusing on heart-related and chronic cardiac care portfolios.

Why should medical distributors include Isofyle 30 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for nitrate-class medicines used in angina pectoris, coronary artery disease, and long-term cardiac management. Isofyle 30 Tablet helps strengthen a comprehensive cardiology product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Isofyle 30 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Isofyle 30 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Isofyle 30 Tablet distribution?

Wholesalers and medical agencies benefit from steady cardiac prescription demand, reliable availability, business margins, and professional support when partnering for Isofyle 30 Tablet distribution.

How can I become a distributor or franchise partner for Isofyle 30 Tablet?

Medical distributors, stockists, and wholesalers interested in Isofyle 30 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.